Singapore markets closed

iX Biopharma Ltd. (42C.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.0420+0.0010 (+2.44%)
At close: 03:14PM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
6,057
5,913
14,390
1,745
985
Cost of revenue
4,036
3,593
2,100
2,127
1,572
Gross profit
2,021
2,320
12,290
-382
-587
Operating expenses
Research development
1,886
2,820
2,332
2,747
2,499
Selling general and administrative
7,479
9,044
9,457
8,300
8,605
Total operating expenses
8,604
10,731
11,017
9,648
10,418
Operating income or loss
-6,583
-8,411
1,273
-10,030
-11,005
Interest expense
439
271
202
174
238
Income before tax
-8,360
-9,706
-4,099
-8,233
-10,499
Income tax expense
1,235
-91
499
1
0
Income from continuing operations
-9,595
-9,615
-4,598
-8,234
-10,499
Net income
-9,595
-9,615
-4,598
-8,234
-10,499
Net income available to common shareholders
-9,595
-9,615
-4,598
-8,234
-10,499
Basic EPS
-0.01
-0.01
-0.01
-0.01
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.01
-0.02
Basic average shares
764,847
764,847
746,125
693,411
647,285
Diluted average shares
764,847
764,847
746,125
693,411
647,285